Loading...
IMCC logo

IM Cannabis Corp.CNSX:IMCC Stock Report

Market Cap CA$8.2m
Share Price
n/a
1Y32.8%
7D0%
1D-40.0%
Portfolio Value
​
View

IM Cannabis Corp.

CNSX:IMCC Stock Report

Market Cap: CA$8.2m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

IM Cannabis (IMCC) Stock Overview

Engages in importation, distribution and sale of medical cannabis products in Israel and Germany. More details

IMCC fundamental analysis
Snowflake Score
Valuation4/6
Future Growth0/6
Past Performance0/6
Financial Health3/6
Dividends0/6

Rewards

Trading at 95.9% below our estimate of its fair value

Risk Analysis

Shareholders have been substantially diluted in the past year

Shares are highly illiquid

Earnings have declined by 0.5% per year over past 5 years

Does not have a meaningful market cap (CA$8M)


IMCC Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

NEW439,757 members

Join community and earn perks

Gain real feedbackFrom our editorial team, personally. Not silence.
Grow your followingReal investors. The kind who actually invest, not scroll past.
Unlock free accessFree premium subscription for consistent and quality authors.
Learn moreCreate Narrative
B
BlackGoat
R
RockeTeller
I
Investingwilly
D
davidlsander
439,757 investors already sharing narratives
View all narratives

IM Cannabis Corp. Competitors

Price History & Performance

Summary of share price highs, lows and changes for IM Cannabis
Historical stock prices
Current Share PriceCA$5.10
52 Week HighCA$9.70
52 Week LowCA$1.75
Beta3.17
1 Month Change131.82%
3 Month Change91.73%
1 Year Change32.81%
3 Year Change-91.67%
5 Year Change-97.88%
Change since IPO-96.63%

Recent News & Updates

Recent updates

Analysis Article • Mar 05

A Piece Of The Puzzle Missing From IM Cannabis Corp.'s (CSE:IMCC) Share Price

When close to half the companies operating in the Pharmaceuticals industry in Canada have price-to-sales ratios (or...
Analysis Article • Sep 13

Slammed 28% IM Cannabis Corp. (CSE:IMCC) Screens Well Here But There Might Be A Catch

IM Cannabis Corp. ( CSE:IMCC ) shareholders won't be pleased to see that the share price has had a very rough month...
Analysis Article • Jul 30

A Piece Of The Puzzle Missing From IM Cannabis Corp.'s (CSE:IMCC) Share Price

When you see that almost half of the companies in the Pharmaceuticals industry in Canada have price-to-sales ratios (or...
Analysis Article • Jul 19

Potential Upside For IM Cannabis Corp. (CSE:IMCC) Not Without Risk

With a price-to-sales (or "P/S") ratio of 0.3x IM Cannabis Corp. ( CSE:IMCC ) may be sending bullish signals at the...
Analysis Article • Dec 24

Health Check: How Prudently Does IM Cannabis (CSE:IMCC) Use Debt?

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Analysis Article • Feb 05

Don't Ignore The Fact That This Insider Just Sold Some Shares In IM Cannabis Corp. (CSE:IMCC)

Investors may wish to note that the Director of IM Cannabis Corp. , Rafael Gabay, recently netted CA$50k from selling...
Analysis Article • Jan 08

What Percentage Of IM Cannabis Corp. (CSE:IMCC) Shares Do Insiders Own?

The big shareholder groups in IM Cannabis Corp. ( CSE:IMCC ) have power over the company. Insiders often own a large...

Shareholder Returns

IMCCCA PharmaceuticalsCA Market
7D0%-1.0%-1.8%
1Y32.8%4.6%22.6%

Return vs Industry: IMCC exceeded the Canadian Pharmaceuticals industry which returned -57.4% over the past year.

Return vs Market: IMCC exceeded the Canadian Market which returned 15.6% over the past year.

Price Volatility

Is IMCC's price volatile compared to industry and market?
IMCC volatility
IMCC Average Weekly Movementn/a
Pharmaceuticals Industry Average Movement8.3%
Market Average Movement9.3%
10% most volatile stocks in CA Market16.3%
10% least volatile stocks in CA Market3.7%

Stable Share Price: IMCC's share price has been volatile over the past 3 months compared to the Canadian market.

Volatility Over Time: Insufficient data to determine IMCC's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
200895Oren Shusterimcannabis.com

IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel and Germany. It provides medical cannabis dried flowers; and cannabis extracts under the IMC, BLKMT, WAGNERS, and LOT420 brands. The company serves medical patients.

IM Cannabis Corp. Fundamentals Summary

How do IM Cannabis's earnings and revenue compare to its market cap?
IMCC fundamental statistics
Market capCA$8.18m
Earnings (TTM)-CA$4.69m
Revenue (TTM)CA$54.47m
0.3x
P/S Ratio
-3.4x
P/E Ratio

Is IMCC overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
IMCC income statement (TTM)
RevenueCA$54.47m
Cost of RevenueCA$44.35m
Gross ProfitCA$10.12m
Other ExpensesCA$14.81m
Earnings-CA$4.69m

Last Reported Earnings

Mar 31, 2025

Next Earnings Date

n/a

Earnings per share (EPS)-1.52
Gross Margin18.58%
Net Profit Margin-8.61%
Debt/Equity Ratio481.3%

How did IMCC perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/06/10 21:27
End of Day Share Price 2025/06/02 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

IM Cannabis Corp. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Aaron GreyAlliance Global Partners